NCT01885130已完成不适用
100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Galderma R&D
- 入组人数
- 100
- 主要终点
- area of erythema and edema is measured
研究概览
简要总结
Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Not currently under a doctor's care
- •Free of dermatological or systemic disorder which would interfere with the results
- •Free of any acute or chronic disease
- •Will complete a preliminary medical history form and are in general good health
- •Can read, understand, and sign informed consent
排除标准
- •Under 18 years old
- •Currently under doctor's care
- •currently taking any medication
- •History of acute or chronic disease
- •Diagnosed with chronic skin allergies
- •Pregnant or lactating
研究组 & 干预措施
Cetaphil Daily Advance Ultra Hydrating Lotion
Experimental
All subjects receive Cetaphil Daily Advance Ultra Hydrating Lotion
干预措施: Cetaphil Daily Advance Ultra Hydrating Lotion (Other)
结局指标
主要结局
area of erythema and edema is measured
时间窗: 3 consecutive weeks
9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body WashSkin IrritationNCT01892410Galderma R&D100
已完成
不适用
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing LotionSkin IrritationNCT01892423Galderma R&D146
已完成
不适用
Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50Skin IrritationNCT01887860Galderma R&D100
已完成
不适用
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial CleanserSkin IrritationNCT01888887Galderma R&D200
已完成
不适用
14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - ChameleonDermal IrritationNCT02737618Church & Dwight Company, Inc.35